药物过量使用头痛:法国的一项药监测研究
Mohamad Houssam Al Balkhi1, Julien Moragny1, Solène M Laville2
1Pharmacovigilance Center, Department of Clinical Pharmacology, Amiens-Picardie University Medical Center, 80054 Amiens, France.
Therapie
|March 8, 2024
概括
药物过度使用头痛 (MOH) 是一种显著的药物不良反应 (ADR). 对法国药监数据的分析显示,特定药物类别的MOH报告率很高,需要更新产品警告.
科学领域:
- 药物监督 药物监督 药物监督
- 神经学 神经学
- 药品安全 药品安全
背景情况:
- 过度使用药物可能导致依赖和药物过度使用头痛 (MOH),药物不良反应 (ADR).
- 了解涉及MOH的特定药物和患者人口统计数据对于预防和管理至关重要.
研究的目的:
- 分析与药物过量使用头痛 (MOH) 相关的药物不良反应 (ADR) 报告.
- 确定法国国家药监数据库 (FPVD) 中报告的MOH病例的药物类别和特征.
主要方法:
- 从2000年1月到2023年6月在FPVD报告的MOH病例的回顾性分析.
- 包括符合国际头痛疾病分类标准的病例或MOH的医学诊断,不包括自愿中毒报告.
- 专注于针对肌肉骨和神经系统的药物,分析活性成分和可疑药物数量.
主要成果:
- 从2674份与头痛相关的报告中确定了234例MOH病例,患者的中位数年龄为45岁,74.4%为女性.
- 在53.4%的病例中报告了严重的不良反应,其中止痛药 (63.0%),特别是乙氨基,阿片类药物,三药和ergot,是最常见的.
- 药物戒断在84.6%的病例中是成功的;然而,产品特征 (SmPC) 中的警告在涉及的药物类别之间是不一致的.
结论:
- 一些药物类别,包括止痛药,三药和ergot,对MOH的报告率很高.
- 处方者应对这些药物保持谨慎,并且对MOH风险的警告必须包含在所有相关药物类别的SmPC中.
相关概念视频
01:19Pharmacovigilance
833
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
833
01:02Prescription, Nonprescription and Orphan Drugs
728
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
728
01:25Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
61
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
61
01:03Drug Control Governance: Regulatory Bodies and Their Impact
158
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
158
01:11Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K